Warning: members of the public are being contacted by people claiming to work for AXA Investment Managers UK Limited.  Find out more information and what to do by clicking here.

UK Mid Cap strategy - August 2022

  • 25 October 2022 (5 min read)

Material fiscal support planned to protect UK consumer from the unaffordable energy price rises

  • After a brighter month in July, global equity markets fell in August
  • Darktrace, 4Imprint, Energean and RS Group contributed positively
  • Well capitalised and well managed companies continue to reside on the UK market

What’s happening?

After a brighter month in July, global equity markets fell in August, in what is usually a month of low liquidity and insipid returns. As inflation continued to rise, global central banks confirmed they remain committed to aggressively tightening monetary policy. Until inflation and interest rates peak, it is difficult to see financial assets making persistent headway.

The main focus in Europe continues to be the availability and price of wholesale gas, the rising cost of electricity and food price inflation. Although these issues appear to be pushing the crisis in Ukraine off the front pages of the newspapers, they are causally entwined.

Over the month, UK inflation hit another milestone, exceeding double digits as the Consumer Price Index (CPI) rate of inflation hit 10.1%. In an attempt to rein in inflation, the Bank of England raised base rates by 0.5% (its sixth straight raise) to 1.75%.

Recent UK macro-economic newsflow has been unrelentingly negative and this has taken its toll on UK sterling with the rate versus the US dollar at a 35 year low. Many commentators, including the Bank of England are now forecasting a recession in the UK. Whilst this feels inevitable, the depth and length of any recession will be crucial. In this environment, the outperformance of the more internationally focussed FTSE100 versus the more domestically focussed FTSE 250 continued. 

Portfolio positioning and performance

In a volatile and unpredictable month, the strategy underperformed the FTSE 250 Excluding investment Trusts index. From a sector perspective, the underweight in Financials and overweight in Industrials was negative, whereas the overweight positions in Energy and Technology was positive.

Detractors from performance included Revolution Beauty (consumer Discretionary) which put a statement out to the stock market lowering profit guidance and highlighting issues raised by its auditor. The shares in Revolution Beauty have been sold. Other detractors of note include Ascential (Technology), Hill and Smith (Industrial) and Marshalls (Industrial). We remain supportive of these investments and continue to monitor their operational performance closely. Positive stock contributors over the month include positions in Darktrace (Technology) which reported a preliminary take over approach from Thoma Bravo, 4Imprint (Consumer Discretionary), Energean (Energy) and RS Group (Industrials).

We continue to focus on well capitalised companies that have growing profits, cash flows and, where appropriate, dividends. Market volatility was used to add to and reduce core holdings. Over the month, we sold the holdings in XP Power, Boohoo and Revolution Beauty. A new holding was taken in JTC.

Outlook

At the time of writing, the prolonged process of electing a new conservative party leader and Prime Minister has finished, with Liz Truss achieving a slimmer majority than predicted. Leaked reports suggest that material fiscal support (some reports suggest up to £140bn) is planned in order to protect the UK consumer from the unaffordable energy price rises implied by the wholesale gas price. If this becomes a reality, it will potentially reduce UK inflation and could mean that UK inflation has peaked. Global supply chains are easing, the price of West Texas Intermediate crude oil has fallen back to circa $85 from circa $125 (just after Russia’s invasion of Ukraine) and the cost of moving freight from Asia to the West Coast of the US is down 70% from its peak. Wage inflation remains stubborn and it remains to be seen whether the balance of power moves demonstrably from the employee to the employer as the economy slows.

UK equites, in many parts of the UK stock market, have priced in a very poor economic outlook. This may transpire, yet innovative, well capitalised and well managed companies continue to reside on the UK market that will increase their market share through this economic cycle and will, in time, enjoy materially higher valuations. This combination of factors, together with weak sterling relative to the US dollar, is catalysing more take over approaches of UK companies. This will continue and illustrates the opportunity available for investors with a rational investment horizon, driven by fundamentals and not short term hysteria.

We remain focused on UK and internationally exposed businesses, where the fundamental profit drivers remain entrenched and equity holders benefit from the capital allocated and risks taken by management. We continue to believe that a rewarding strategy is to actively invest in UK-listed companies that are compounding their earnings and dividends, where corporate governance is world leading, where contract law and title law are dependable, and where company management teams are permanently accessible.

No assurance can be given that the UK Mid Cap Strategy will be successful. Investors can lose some or all of their capital invested. The UK Mid Cap strategy is subject to risks including; Equity; Smaller companies risk; Liquidity risk.

Download the full monthly perspective
Download report (219.61 KB)
Investment strategies

Equities

Equity investing offers the opportunity to share in the returns generated by companies around the world, whether they are established leaders or dynamic smaller companies.

Find out more

Visit our fund centre

Equity
UK Mid Cap strategy

The aim of this strategy is to provide long-term capital growth.

View funds

Related Articles

Equities

UK Mid Cap strategy - April 2024

Equities

UK Mid Cap strategy - September 2023

Equities

Longevity Economy strategy - September 2023

  • by Stephen Kelly
  • 09 October 2023 (5 min read)

    Disclaimer

    Not for Retail distribution: This document is intended exclusively for Professional, Institutional, Qualified or Wholesale Clients / Investors only, as defined by applicable local laws and regulation. Circulation must be restricted accordingly.

    Past performance is not a guide to current or future performance, and any performance or return data displayed does not take into account commissions and costs incurred when issuing or redeeming units. The value of investments, and the income from them, can fall as well as rise and investors may not get back the amount originally invested. Exchange-rate fluctuations may also affect the value of their investment.  Due to this and the initial charge that is usually made, an investment is not usually suitable as a short term holding.

    This document is for informational purposes only and does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities. The strategies discussed in this document may not be available in your jurisdiction.

    Due to its simplification, this document is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee forecasts made will come to pass. Data, figures, declarations, analysis, predictions and other information in this document is provided based on our state of knowledge at the time of creation of this document. Whilst every care is taken, no representation or warranty (including liability towards third parties), express or implied, is made as to the accuracy, reliability or completeness of the information contained herein. Reliance upon information in this material is at the sole discretion of the recipient. This material does not contain sufficient information to support an investment decision.

    Please note that the management company reserves the right, at any time, to no longer market the product(s) mentioned in this communication in an European Union country by notification to its authority of supervision in accordance with European passport rules. In the event of dissatisfaction with the products or services, you have the right to make a complaint either with the marketer or directly with the management company (more information on our complaints policy available in English here). You also have the right to take legal or extra-judicial action at any time if you reside in one of the countries of the European Union. The European online dispute resolution platform allows you to enter a complaint form (by clicking here) and informs you, depending on your jurisdiction, about your means of redress (by clicking here).

    Issued in the UK by AXA Investment Managers UK Limited, which is authorised and regulated by the Financial Conduct Authority in the UK. Registered in England and Wales No: 01431068. Registered Office 22 Bishopsgate, London EC2N 4AJ. In other jurisdictions, this document is issued by AXA Investment Managers SA’s affiliates in those countries.

    Risk Warning

    The value of investments, and the income from them, can fall as well as rise and investors may not get back the amount originally invested. 

    Are you an IFA or other Professional Investor ?

    Are you a financial advisor, institutional, or other professional investor?

    This section is for professional investors only. You need to confirm that you have the required investment knowledge and experience to view this content. This includes understanding the risks associated with investment products, and any other required qualifications according to the rules of your jurisdiction.